miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation
Yosuke Mizuno(Saitama Medical University), Yasushi Okazaki(Saitama Medical University), Hideo Tashiro(RIKEN), Takenobu Katagiri(Saitama Medical University), Yukiko Kanesaki-Yatsuka(Saitama Medical University), Yasumitsu Kondoh(RIKEN), Masayoshi Maruyama(Saitama Medical University), Ken Yagi(RIKEN Center for Integrative Medical Sciences), Tomoyuki Amemiya(RIKEN), Tatsuo Suda(SHOWA Medical University), Yoshimi Tokuzawa(Saitama Medical University), Toru Fukuda(Saitama Medical University), Akihiko Okuda(Japan Science and Technology Agency)
Cited by 295
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs
|Nature|2002|1.6k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665